NCT05297097View on ClinicalTrials.gov

The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers

PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 30, 2022

Conditions

Aging

Interventions

DIETARY_SUPPLEMENT

Trulacta breastmilk supplement

one supplement daily

Trial Locations (1)

32819

RECRUITING

Central Florida Wellness, Orlando

Sponsors

Collaborators (1)

Adventa Biosciences

All Listed Sponsors

collaborator

Adventa Biosciences

UNKNOWN

lead

TruDiagnostic

INDUSTRY

NCT05297097 - The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers | Biotech Hunter | Biotech Hunter